Similar articles

• [Utilization of high-dose norethindrone in the treatment of some genital hormono-dependent cancers].

  Sonkin R, Coudeyras M, Thévenet M. Sonkin R, et al. Gynecol Obstet (Paris). 1969 Aug-Sep;68(4):355-72. Gynecol Obstet (Paris). 1969. PMID: 5354375 French. No abstract available.
• [Progestational hormones in the treatment of gynecologic cancers].

  Soutoul JH, Lagabrielle V. Soutoul JH, et al. Presse Med (1893). 1969 Feb 8;77(7):247-9. Presse Med (1893). 1969. PMID: 5795418 French. No abstract available.
• [Progestagens in gynecologic oncology].

  Gorins A. Gorins A. Cah Med. 1973 Nov 30;14(13):1056-63. Cah Med. 1973. PMID: 4134359 French. No abstract available.
• Use of progestational agents in the management of metastatic carcinoma of the endometrium.

  Kistner RW, Griffiths CT. Kistner RW, et al. Clin Obstet Gynecol. 1968 Jun;11(2):439-56. Clin Obstet Gynecol. 1968. PMID: 4879374 Review. No abstract available.
• [Hormone-dependent oncological diseases in menopausal women].

  Tomov S, Baichev G, Gorchev G. Tomov S, et al. Akush Ginekol (Sofiia). 2000;39(3):41-5. Akush Ginekol (Sofiia). 2000. PMID: 11187996 Review. Bulgarian. No abstract available.